{"database": "lobbying", "table": "lobbying_activities", "rows": [[1584532, "629b4407-1af9-47d0-8540-507e26a4ce87", "Q3", "PHARMAVITE LLC", 286074, "PHARMAVITE LLC", 2014, "third_quarter", "FOO", "Discussed FDA's NDI guidance document issued 2011 and need to have FDA issue revised draft.  Support for both HR 4771 and SB 2012.  Support for full enforcement of DSHEA.\n\nDept of Commerce meeting - discuss regulatory hurdles relative to marketing dietary supplement products in China.", "Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE", null, 60000, 0, 0, "2014-10-13T14:45:08.020000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1584532"], "units": {}, "query_ms": 7.427039789035916, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}